US Patent 7303893 Crystallization of c-KIT tyrosine kinase leading to autoinhibited crystal structure

Patent 7303893 was granted and assigned to Takeda (company) on December, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7303893

Date of Patent

December 4, 2007

Patent Application Number

10651494

Date Filed

August 28, 2003

Patent Citations Received

‌

US Patent 11987626 Treatment of eosinophil or mast cell related disorders

‌

US Patent 11884699 Anti-KIT antibodies and uses thereof

‌

US Patent 11891452 Anti-kit antibodies and uses thereof

Patent Primary Examiner

Nashaat T. Nashed

Patent abstract

Provided are crystals relating to the autoinhibited structure of c-KIT tyrosine kinase (c-KIT) and its various uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7303893 Crystallization of c-KIT tyrosine kinase leading to autoinhibited crystal structure

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API